Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

894 ARTíCULOS , VIENDO DEL 76 AL 90

PUBMED

Association of Catechol-O-Methyltransferase Gene rs4680 Polymorphism and Levodopa Induced Dyskinesia in Parkinson's Disease: A Meta-Analysis and Systematic Review

Dwivedi A, Dwivedi N, Kumar A, Singh VK, Pathak A, Chaurasia RN, Mishra VN, Mohanty S, Joshi D.

J Geriatr Psychiatry Neurol. 2022 May 22:8919887221103580. doi: 10.1177/08919887221103580. Online ahead of print.

0

0

0

PUBMED

Negative DAT-SPECT in Old Onset Parkinson's Disease: An Additional Pitfall?

Palermo G, Giannoni S, Depalo T, Frosini D, Volterrani D, Siciliano G, Bonuccelli U, Ceravolo R.

Mov Disord Clin Pract. 2022 Apr 15;9(4):530-534. doi: 10.1002/mdc3.13441. eCollection 2022 May.

0

0

0

PUBMED

Roles of neuronal toll-like receptors in neuropathic pain and central nervous system injuries and diseases

Acioglu C, Heary RF, Elkabes S.

Brain Behav Immun. 2022 May;102:163-178. doi: 10.1016/j.bbi.2022.02.016. Epub 2022 Feb 14.

0

0

0

PUBMED

Pharmacotherapy for mild traumatic brain injury: an overview of the current treatment options

Gao C, Nie M, Huang J, Tian Y, Wang D, Zhang J, Jiang R.

Expert Opin Pharmacother. 2022 May;23(7):805-813. doi: 10.1080/14656566.2022.2054328. Epub 2022 Mar 20.

0

0

0

PUBMED

A Comprehensive Review on Function of miR-15b-5p in Malignant and Non-Malignant Disorders

Ghafouri-Fard S, Khoshbakht T, Hussen BM, Jamal HH, Taheri M, Hajiesmaeili M.

Front Oncol. 2022 May 2;12:870996. doi: 10.3389/fonc.2022.870996. eCollection 2022.

0

0

0

PUBMED

Increased Stroke Risk in Patients with Parkinson's Disease with LRRK2 Mutations

Grisanti S, Ferri L, Cavallieri F, Fioravanti V, Vincenzi C, Toschi G, Grisendi I, Sabadini R, Paul JJ, Bauer P, Zedde M, Valzania F.

Mov Disord. 2022 May;37(5):1117-1118. doi: 10.1002/mds.28996.

0

0

0

PUBMED

Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinic

Frouni I, Huot P.

Neurodegener Dis Manag. 2022 May 19. doi: 10.2217/nmt-2021-0055. Online ahead of print.

0

0

0

PUBMED

Quantitative assessment of the effect of FGF20 rs1721100 and rs12720208 variant on the risk of sporadic Parkinson's disease: a meta-analysis

Quan W, Li J, Liu L, Zhang Q, Qin Y, Pei X, Chen J.

Neurol Sci. 2022 May;43(5):3145-3152. doi: 10.1007/s10072-021-05754-6. Epub 2021 Nov 29.

0

0

0

PUBMED

Development of Prodrugs for Treatment of Parkinson's Disease: New Inorganic Scaffolds for Blood-Brain Barrier Permeation

Di Battista V, Hey-Hawkins E.

J Pharm Sci. 2022 May;111(5):1262-1279. doi: 10.1016/j.xphs.2022.02.005. Epub 2022 Feb 17.

0

0

0

PUBMED

Is there a need for a novel algorithm for accessory pathways localization?

Nayfeh M, Refaat MM.

J Cardiovasc Electrophysiol. 2022 May;33(5):962-965. doi: 10.1111/jce.15414. Epub 2022 Feb 26.

0

0

0

PUBMED

Protective effects of functional foods against Parkinson's disease: A narrative review on pharmacology, phytochemistry, and molecular mechanisms

Iranshahy M, Javadi B, Sahebkar A.

Phytother Res. 2022 May;36(5):1952-1989. doi: 10.1002/ptr.7425. Epub 2022 Mar 4.

0

0

0

PUBMED

The potential applications of traditional Chinese medicine in Parkinson's disease: A new opportunity

Chen J, Xu J, Huang P, Luo Y, Shi Y, Ma P.

Biomed Pharmacother. 2022 May;149:112866. doi: 10.1016/j.biopha.2022.112866. Epub 2022 Mar 31.

0

0

0

PUBMED

Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism

Furderer ML, Hertz E, Lopez GJ, Sidransky E.

Int J Mol Sci. 2022 May 23;23(10):5842. doi: 10.3390/ijms23105842.

0

0

0

PUBMED

Systematic literature review of the epidemiology of glyphosate and neurological outcomes

Chang ET, Odo NU, Acquavella JF.

Int Arch Occup Environ Health. 2022 May 23. doi: 10.1007/s00420-022-01878-0. Online ahead of print.

0

0

0

PUBMED

Convergent Molecular Pathways in Type 2 Diabetes Mellitus and Parkinson's Disease: Insights into Mechanisms and Pathological Consequences

Xxxx S, Ahmad MH, Rani L, Mondal AC.

Mol Neurobiol. 2022 May 16. doi: 10.1007/s12035-022-02867-7. Online ahead of print.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy